GlassScriptPhysician profile
Ashley Bailey Hink
NPI 1700225745
$1,420.39
in general payments reported to CMS, 2019-2025
9 companies · $382 in 2025
The $382 reported for 2025 was more than what a typical Trauma Surgery provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.68 · 2020: $17.87 · 2021: $214 · 2022: $130 · 2023: $163 · 2024: $474 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,018.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,018.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $386.52 | 2024-2025 | Irrisept |
| Kerecis Limited | $274.49 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Avita Medical Americas, LLC | $264.13 | 2021-2025 | Recell, Permeaderm, Cohealyx |
| Integra Lifesciences Corporation | $256.17 | 2021-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Davol INC. | $62.35 | 2025 | Phasix Mesh |
| Acera Surgical, INC. | $60.63 | 2021 | |
| Ethicon US, LLC | $57.55 | 2019-2020 | |
| Medtronic, INC. | $39.72 | 2024 | Signia |
| Medline Industries LP | $18.83 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Hink listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.